Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma. [PDF]
Tunuguntla A, Suresh TN, Pn S.
europepmc +1 more source
P126 IMMUNOHISTOCHEMICAL EXPRESSION OF P53, CDX2 AND BETA-CATENIN IN INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED, COMPARED TO SPORADIC COLORECTAL CANCER: FURTHER EVIDENCE FOR DIFFERENT CARCINOGENIC PATHWAYS [PDF]
Cécile Laurent +5 more
openalex +1 more source
Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong +5 more
wiley +1 more source
POLRMT over-expression is linked to WNT/beta-catenin signaling, immune infiltration, and unfavorable outcomes in lung adenocarcinoma patients. [PDF]
Huang Y +10 more
europepmc +1 more source
MS436 competitively binds to the BD1 domain of Brd4, thereby suppressing Brd4 induced degradation of tight junction proteins via the Rnf43‐Fzd4‐β‐catenin signaling pathway. Consequently, this attenuation of degradation reduces blood‐brain barrier leakage, leading to an improved overall prognosis after stroke.
Chenxiao Li +10 more
wiley +1 more source
HMMR mediates progression of nasopharyngeal carcinoma by inhibiting FAM83D ubiquitination and activating beta-catenin signaling pathway. [PDF]
Zhong F +17 more
europepmc +1 more source
Differential Intracellular Protein Distribution in Cancer and Normal Cells-Beta-Catenin and CapG in Gynecologic Malignancies. [PDF]
Fernandez MK, Sinha M, Renz M.
europepmc +1 more source
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability [PDF]
Jenny Brändstedt +5 more
openalex +1 more source

